Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system

Aune, 1982, Metabolism of 2-acetylaminofluorene (AAF) by rabbit pulmonary and hepatic microsomes and by microsomes prepared from Clara and alveolar type II cells of lung, Toxicologist, 2, 142 Beranek, 1982, Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene, 79, 5175 Bissell, 1980, Phenotypic stability of adult rat hepatocytes in primary monolayer culture, Ann. N.Y. Acad. Sci., 349, 85, 10.1111/j.1749-6632.1980.tb29518.x Brouns, 1981, Metabolic activation of 2-acetylaminofluorene by isolated rat liver cells through different pathways leading to hepatocellular DNA-repair and bacterial mutagenesis, Toxicology, 19, 67, 10.1016/0300-483X(81)90066-4 Cameron, 1979, Ascorbic acid and cancer: A review, Cancer Res., 39, 663 DeBaun, 1970, Reactivity in vitro of the carcinogen N-hydroxy-2-acetylaminofluorene: increase by sulfate ion, Science, 167, 184, 10.1126/science.167.3915.184 Dybing, 1977, Hexachlorobenzene induction of 2,4-diaminoanisole mutagenicity in vitro, Acta Pharmacol. Toxicol., 40, 575, 10.1111/j.1600-0773.1977.tb02113.x Felton, 1976, Genetic differences in 2-acetylaminofluorene mutagenicity in vitro associated with mouse hepatic aryl hydrocarbon hydroxylase induced by polycyclic aromatic hydrocarbons, Mol. Pharmacol., 12, 225 Gayda, 1981, Activation of aflatoxin B1 by primary cultures of adult rat hepatocytes: effects of hepatocyte density, Chem.-Biol. Interact., 35, 255, 10.1016/0009-2797(81)90001-6 Glatt, 1981, Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo[a]pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate, Cancer Res., 41, 270 Hinson, 1981, Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide, Natl. Cancer Inst., Monogr., 58, 113 Holme, 1982, Cytotoxic effects of N-hydroxyparacetamol in suspensions of isolated rat hepatocytes, Acta Pharmacol. Toxicol., 51, 87, 10.1111/j.1600-0773.1982.tb00996.x Hongslo, 1983, The influence of conjugation reactions on the mutagenicity of aromatic amines, Mutation Res., 107, 239, 10.1016/0027-5107(83)90166-5 Irving, 1971, Metabolic activation of N-hydroxy compounds by conjugation, Xenobiotica, 1, 387, 10.3109/00498257109041505 Kaneda, 1981, Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide, J. Natl. Cancer Inst., 67, 549 Ketterer, 1982, The role of nonenzymatic reactions of glutathione in xenobiotic metabolism, Drug Met. Rev., 13, 161, 10.3109/03602538209002234 Lake, 1982, The effect of hepatocyte culture conditions on cytochrome P-450 linked drug metabolizing enzymes, Biochem. Pharmacol., 31, 2141, 10.1016/0006-2952(82)90438-5 Lotlikar, 1967, Species variations in the N- and ring-hydroxylation of 2-acetylaminofluorene and effects of 3-methylcholanthrene pretreatment, 104, 341 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 McCann, 1975, Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals, 72, 5135 McQueen, 1982, Susceptibility of hepatocytes from rapid and slow acetylator rabbits to the genotoxicity of aromatic amines Meerman, 1980, Inhibition of sulfate conjugation of N-hydroxy-2-acetylaminofluorene in isolated perfused rat liver and in the rat in vivo by pentachlorophenol and low sulfate, Cancer Res., 40, 3772 Meerman, 1982, Identification of glutathione conjugates formed from N-hydroxy-2-acetylaminofluorene in the rat, Chem.-Biol. Interact., 39, 149, 10.1016/0009-2797(82)90118-1 Miller, 1978, Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address, Cancer Res., 38, 1479 Miller, 1969, The metabolic activation of carcinogenic aromatic amines and amides, Prog. Exp. Tumor Res., 11, 273, 10.1159/000391399 Miller, 1964, The comparative carcinogenicities of 2-acetylaminofluorene and its N-hydroxymetabolite in mice, hamster and guinea pigs, Cancer Res., 24, 2018 Moldeus, 1979, Regulation of glucuronidation and sulfate conjugation in isolated hepatocytes, Drug Metab. Dispos., 7, 416 Mulder, 1977, Role of sulfotransferase from rat liver in the mutagenicity of N-hydroxy-2-acetylaminofluorene in Salmonella typhimurium, Biochem. Pharmacol., 26, 1356, 10.1016/0006-2952(77)90100-9 Mulder, 1982, Formation and identification of glutathione conjugates from 2-nitrosofluorene and N-hydroxy-2-aminofluorene, Chem.-Biol. Interact., 39, 111, 10.1016/0009-2797(82)90010-2 Sakai, 1978, Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse, Cancer Res., 38, 2058 Schut, 1978, Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat, Mol. Pharmacol., 14, 682 Seglen, 1975, Preparation of isolated rat liver cells, Meth. Cell Biol., 13, 29, 10.1016/S0091-679X(08)61797-5 Thorgeirsson, 1977, The Ah locus and the metabolism of chemical carcinogens and other foreign compounds, Adv. Cancer Res., 25, 149, 10.1016/S0065-230X(08)60634-X Thorgeirsson, 1980, Effect of ascorbic acid on in vitro mutagenicity and in vivo covalent binding of N-hydroxy-2-acetylaminofluorene in the rat, Mutation Res., 70, 395, 10.1016/0027-5107(80)90030-5 Walker, 1979, Free radical activation of N-hydroxy-2-acetylaminofluorene by methemoglobin and hydrogen peroxide, Cancer Biochem. Biophys., 4, 87 Weeks, 1978, Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-2-fluorenylacetamide in Salmonella typhimurium, Cancer Res., 38, 613 Weisburger, 1981, N-Substituted aryl compounds in carcinogenesis and mutagenesis, Natl. Cancer Inst. Monogr., 58, 1 Weisburger, 1956, Urinary metabolites of the carcinogen N-2-fluorenylacetamide, Cancer Res., 17, 345 Weisburger, 1973, Biochemical formation and pharmacological, toxicological and pathological properties of hydroxylamines and hydroxamic acids, Pharmacol. Rev., 25, 1 Wirth, 1981, Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system: role of N–O acetyltransferase and sulfotransferase from rat liver, Mol. Pharmacol., 19, 337 Yamazoe, 1980, Reduction of N-hydroxy-2-acetylaminofluorene by liver microsomes, Biochem. Pharmacol., 29, 2183, 10.1016/0006-2952(80)90196-3